Blum Robert I — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Blum Robert I has filed 6 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $10.85M.

Profile

Robert I. Blum is the President and CEO of Cytokinetics Inc, a biopharmaceutical company specializing in muscle-related therapies. He has played a significant role in advancing the company's focus on developing treatments for conditions such as amyotrophic lateral sclerosis and heart failure.

Board memberships

• Cytokinetics Inc

Awards & honors

• Led Cytokinetics through multiple clinical trials
• Focused on innovative muscle therapies
• Expanded the company's pipeline of treatments

Recent Transactions

Companies — Last 90 Days

• CYTOKINETICS INC (CYTK) — 6 filings, last 2026-07-14

Frequently Asked Questions

Who is Blum Robert I?

Robert I. Blum is the President and CEO of Cytokinetics Inc, a biopharmaceutical company specializing in muscle-related therapies. He has played a significant role in advancing the company's focus on developing treatments for conditions such as amyotrophic lateral sclerosis and heart failure.…

How many SEC Form 4 filings has Blum Robert I submitted recently?

6 primary Form 4 filings in the last 90 days, covering 1 company.

Has Blum Robert I been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 29 open-market sales ($10.85M) across all tracked filings.

Where can I see all of Blum Robert I's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week